ANESSA JOHNSON: Open Payments
NPI 1962114116 · CLINTON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$541 in 41 payments from 7 companies in 2025. Trend: 2023 $29 · 2024 $249 · 2025 $541
Food & beverage: $541
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 23 | $190 |
| ABBVIE INC. | 10 | $169 |
| Supernus Pharmaceuticals, Inc. | 3 | $67 |
| Neurocrine BioSciences, Inc. | 2 | $56 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $24 |
| Novo Nordisk Inc | 1 | $20 |
| Exact Sciences Corporation | 1 | $15 |
Products named: CAPLYTA, VRAYLAR, Qelbree, INGREZZA, Kerendia, Ozempic, Cologuard Collection Kit.
Industry payments across LA — which companies pay providers there.
